Sep 2026· Journal of Imaging· Vol 12, pp. 446· 0 citations· 36 references
Medicine
TL;DR
Fusion gains were modest and task-dependent; enrichment analysis linked the nodal signal to loss of smooth muscle programs, consistent with established dedifferentiation biology.
Abstract
Multimodal studies of prostate cancer typically report aggregate fusion gains from histology and transcriptomics but rarely characterize when each modality is informative. We asked whether morphology and transcriptomics contribute differently to distinct clinical endpoints, using Gleason grading and nodal status prediction. On 401 TCGA-PRAD patients with matched whole-slide images, bulk RNA sequencing, and clinical data, we evaluated 45 morphological configurations, seven RNA configurations, and six fusion strategies across four grading formulations, T-stage, and N-stage. To avoid per-task model selection, morphology used a single fixed configuration (gated ABMIL on UNI features). Contribution estimates used repeated stratified five-fold cross-validation, with a locked conformal-prediction protocol and gene set enrichment analysis. The two endpoints showed opposite modality dependence. For Gleason grade, the fixed morphological model exceeded the best RNA configuration across all 45 configurations (five-class macro-F1: 0.445 versus 0.398). For nodal status, no morphological configuration exceeded AUROC 0.62, whereas transcriptomics reached 0.68 (permutation p = 0.037); a direct interaction test confirmed the reversal (bootstrap 95% CI excluding zero). Fusion gains were modest and task-dependent; enrichment analysis linked the nodal signal to loss of smooth muscle programs, consistent with established dedifferentiation biology. The informative modality is task-dependent: morphology predicts grade, transcriptomics predicts nodal status.
A two-stage AI model predicting pathological complete response to neoadjuvant therapy in breast cancer and transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays'gene selection constraints are developed.
Jungkyu Park, D. Biswas, J. Cappadona et al.· 0 citations
Background: Five-year survival prediction from hematoxylin-and-eosin whole-slide images could support risk stratification, but the task is weakly supervised, and the tissue morphologies carrying prognostic information remain incompletely characterized. Methods: We conducted a retrospective secondary analysis using TCGA...
Hikmat Khan, M. Gurcan, Anil Parwani et al.· 0 citations
into basal-like and classical states is a critical prognostic determinant, yet clinical implementation remains limited by the cost and turnaround time of transcriptomic sequencing. 1 – 3 Although routine histopathology captures rich morphological features, deep learning models often lack a principled connection to gene...
Alejandro Leyva, Abdul Rehman Akbar, M. K. Niazi· Signal Transduction and Targ...· 0 citations
Muscle-invasive bladder cancer (MIBC) exhibits significant heterogeneity in clinical outcomes and treatment responses. While gene expression profiling has provided important biological and prognostic insight, transcriptomic assays are not routinely incorporated into standard clinical practice, in part due to cost. AI m...
I. F. Mathisen, F. Koll, R. Mayer et al.· Modern Pathology· 0 citations
High-risk non-muscle-invasive bladder cancer (HR-NMIBC) carries substantial risks of recurrence and progression, while current clinical risk stratification remains limited. CHIMERA was established as a multimodal AI challenge to benchmark prediction in HR-NMIBC under standardized evaluation. Task BRS predicts RNA-seq-d...
Predicting molecular receptor status, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), directly from routine hematoxylin and eosin (H&E)-stained whole-slide images (WSIs) could reduce reliance on costly immunohistochemistry, but image-only models have no...